Drug Type AAV based gene therapy |
Synonyms AAV based urocortin 2 gene therapy (Renova Therapeutics) |
Target |
Mechanism UCN2 gene transference(urocortin 2 gene transference) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Abdominal Obesity Metabolic Syndrome | Preclinical | US | - | |
Diabetes Mellitus, Type 2 | Preclinical | US | - | |
Heart Failure | Preclinical | US | - | |
Nonalcoholic Steatohepatitis | Preclinical | US | - | |
Obesity | Preclinical | US | - |